JBC PeproTech; Our Business is Cytokines!

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M413687200 on May 31, 2005

J. Biol. Chem., Vol. 280, Issue 31, 28507-28518, August 5, 2005
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
280/31/28507    most recent
M413687200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gray, S. G.
Right arrow Articles by Dangond, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gray, S. G.
Right arrow Articles by Dangond, F.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Functional Characterization of JMJD2A, a Histone Deacetylase- and Retinoblastoma-binding Protein*{boxs}

Steven G. Gray,abcde Antonio H. Iglesias,ae Fernando Lizcano,aef Raul Villanueva,a Sandra Camelo,a Hisaka Jingu,g Bin T. Teh,c Noriyuki Koibuchi,g William W. Chin,h Efi Kokkotou,i and Fernando Dangondaj

From the aLaboratory of Transcriptional and Immune Regulation, Brigham and Women's Hospital Laboratories, Cambridge, Massachusetts 02139, the bReceptor Biology Laboratory, Hagedorn Research Institute, Novo Nordisk, Niels Steensens Vej, Gentofte DK-2820, Denmark, the cLaboratory of Cancer Genetics, Van Andel Research Institute, Grand Rapids, Michigan 49503, the dThoracic Oncology Research Group, Departments of Oncology and Clinical Medicine, Institute of Molecular Medicine, Trinity Sciences Health Center, St. James's Hospital, Dublin 8, Ireland, the fLaboratory of Molecular Biology, School of Medicine, La Sabana University, Bogota, Colombia, the gDepartment of Physiology, Gunma University School of Medicine, Maebashi, Gunma 371-8511, Japan, hGene Regulation Research, Eli Lilly Co., Indianapolis, Indiana 46285, the iMolecular Medicine Laboratory and Macromolecular Crystallography Unit, Division of Experimental Medicine, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02115

To effectively direct targeted repression, the class I histone deacetylases (HDACs) associate with many important regulatory proteins. In this paper we describe the molecular characterization of a member of the Jumonji domain 2 (JMJD2) family of proteins, and demonstrate its binding to both class I HDACs and the retinoblastoma protein (pRb). JMJD2 proteins are characterized by the presence of two leukemia-associated protein/plant homeodomain (LAP/PHD) zinc fingers, one JmjN, one JmjC (containing an internal retinoblastoma-binding protein 2 (RBBP2)-like sequence), and two Tudor domains. The first member of this group, JMJD2A, is widely expressed in human tissues and cell lines, and high endogenous expression of JMJD2A mRNA was found in several cell types, including human T-cell lymphotropic virus 1 (HTLV-1)-infected cell lines. JMJD2A and JMJD2B exhibit cell type-specific responses to the HDAC inhibitor trichostatin A. We show that the JMJD2A protein associates in vivo with pRb and class I HDACs, and mediates repression of E2F-regulated promoters. In HTLV-1 virus-infected cells, we find that JMJD2A binds to the viral Tax protein. Antibodies to JMJD2A recognize the native protein but also a half-sized protein fragment, the latter up-regulated in THP-1 cells during the G2/M phase of the cell cycle. The ability of JMJD2A to associate with pRb and HDACs and potentiate pRb-mediated repression of E2F-regulated promoters implies an important role for this protein in cell proliferation and oncogenesis.


Received for publication, December 6, 2004 , and in revised form, May 26, 2005.

* This work was supported in part by a grant from the Van Andel Research Institute (to B. T. T.) and National Institutes of Health Grant CA80084 (to F. D.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

{boxs} The on-line version of this article (available at http://www.jbc.org) contains Fig. S1 and data.

e These authors contributed equally to this work.

j To whom correspondence should be addressed: Laboratory of Transcriptional and Immune Regulation, Brigham and Women's Hospital Laboratories, 3rd floor, 65 Landsdowne St., Cambridge, MA 02139. Tel.: 617-768-8597; Fax: 617-768-8595; E-mail: fdangond{at}rics.bwh.harvard.edu.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Genes Dev.Home page
P. A.C. Cloos, J. Christensen, K. Agger, and K. Helin
Erasing the methyl mark: histone demethylases at the center of cellular differentiation and disease
Genes & Dev., May 1, 2008; 22(9): 1115 - 1140.
[Abstract] [Full Text] [PDF]


Home page
aacredbookHome page
J. D Licht
Understanding Transcription and Epigenetic Modifications
Am. Assoc. Cancer Res. Educ. Book, April 12, 2008; 2008(1): 329 - 334.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Tu, E. M. M. Bulloch, L. Yang, C. Ren, W.-C. Huang, P.-H. Hsu, C.-H. Chen, C.-L. Liao, H.-M. Yu, W.-S. Lo, et al.
Identification of Histone Demethylases in Saccharomyces cerevisiae
J. Biol. Chem., May 11, 2007; 282(19): 14262 - 14271.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
G. Zupkovitz, J. Tischler, M. Posch, I. Sadzak, K. Ramsauer, G. Egger, R. Grausenburger, N. Schweifer, S. Chiocca, T. Decker, et al.
Negative and Positive Regulation of Gene Expression by Mouse Histone Deacetylase 1
Mol. Cell. Biol., November 1, 2006; 26(21): 7913 - 7928.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
B. D. Fodor, S. Kubicek, M. Yonezawa, R. J. O'Sullivan, R. Sengupta, L. Perez-Burgos, S. Opravil, K. Mechtler, G. Schotta, and T. Jenuwein
Jmjd2b antagonizes H3K9 trimethylation at pericentric heterochromatin in mammalian cells
Genes & Dev., June 15, 2006; 20(12): 1557 - 1562.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
Y. Huang, J. Fang, M. T. Bedford, Y. Zhang, and R.-M. Xu
Recognition of Histone H3 Lysine-4 Methylation by the Double Tudor Domain of JMJD2A
Science, May 5, 2006; 312(5774): 748 - 751.
[Abstract] [Full Text] [PDF]


Home page
DevelopmentHome page
H. MacWilliams, K. Doquang, R. Pedrola, G. Dollman, D. Grassi, T. Peis, A. Tsang, and A. Ceccarelli
A retinoblastoma ortholog controls stalk/spore preference in Dictyostelium
Development, April 1, 2006; 133(7): 1287 - 1297.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2005 by the American Society for Biochemistry and Molecular Biology.